Literature DB >> 1390742

Nonidentical DNA-binding sites of endonuclease NaeI recognize different families of sequences flanking the recognition site.

C C Yang1, M D Topal.   

Abstract

NaeI endonuclease uses a two-site binding mechanism to cleave substrate DNA: reaction-rate studies imply that occupancy of the second DNA site causes an allosteric change in the protein that enables DNA cleavage at the first site [Conrad, M., & Topal, M. D. (1989) Proc. Natl. Acad. Sci. U.S.A. 86, 9707-9711]. Measurements of relative binding affinities for 14-base-pair DNA fragments containing the NaeI recognition sequence GCCGGC and various flanking sequences showed that the two DNA-binding sites are not identical. G.C-rich flanking sequences were preferred by the activator binding site, whereas A.T-rich flanking sequences were preferred by the substrate binding site: GGGTGCCGGCAGGG was preferred 8-fold more by the activator site but 14-fold less by the substrate site than TTTCGCCGGCGTTT. Substitution of pyrimidine or 7-deazapurine for purine immediately 3' to GCCGGC reduced DNA affinity for only the activator site by up to 26-fold, implying that the activator DNA-binding site requires N-7 base contacts immediately flanking GCCGGC. The implications of nonidentical DNA-binding sites, one of which binds a specific DNA site to allosterically activate the other, are discussed.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1390742     DOI: 10.1021/bi00155a019

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  10 in total

1.  Crystal structure of NaeI-an evolutionary bridge between DNA endonuclease and topoisomerase.

Authors:  Q Huai; J D Colandene; Y Chen; F Luo; Y Zhao; M D Topal; H Ke
Journal:  EMBO J       Date:  2000-06-15       Impact factor: 11.598

2.  Diversity of type II restriction endonucleases that require two DNA recognition sites.

Authors:  Merlind Mucke; Detlev H Kruger; Monika Reuter
Journal:  Nucleic Acids Res       Date:  2003-11-01       Impact factor: 16.971

3.  Short-range and long-range context effects on coliphage T4 endonuclease II-dependent restriction.

Authors:  K Carlson; L D Kosturko; A C Nyström
Journal:  J Bacteriol       Date:  1996-11       Impact factor: 3.490

4.  The domain organization of NaeI endonuclease: separation of binding and catalysis.

Authors:  J D Colandene; M D Topal
Journal:  Proc Natl Acad Sci U S A       Date:  1998-03-31       Impact factor: 11.205

5.  Step-wise DNA relaxation and decatenation by NaeI-43K.

Authors:  K Jo; M D Topal
Journal:  Nucleic Acids Res       Date:  1998-05-15       Impact factor: 16.971

6.  Changing endonuclease EcoRII Tyr308 to Phe abolishes cleavage but not recognition: possible homology with the Int-family of recombinases.

Authors:  M D Topal; M Conrad
Journal:  Nucleic Acids Res       Date:  1993-06-11       Impact factor: 16.971

7.  Effects on NaeI-DNA recognition of the leucine to lysine substitution that transforms restriction endonuclease NaeI to a topoisomerase: a model for restriction endonuclease evolution.

Authors:  K Jo; M D Topal
Journal:  Nucleic Acids Res       Date:  1996-11-01       Impact factor: 16.971

8.  Bacteriophage T4 endonuclease II, a promiscuous GIY-YIG nuclease, binds as a tetramer to two DNA substrates.

Authors:  Pernilla Lagerbäck; Evalena Andersson; Christer Malmberg; Karin Carlson
Journal:  Nucleic Acids Res       Date:  2009-08-07       Impact factor: 16.971

9.  Organization of the BcgI restriction-modification protein for the cleavage of eight phosphodiester bonds in DNA.

Authors:  Rachel M Smith; Jacqueline J T Marshall; Alistair J Jacklin; Susan E Retter; Stephen E Halford; Frank Sobott
Journal:  Nucleic Acids Res       Date:  2012-11-11       Impact factor: 16.971

10.  Real-time observation of DNA looping dynamics of Type IIE restriction enzymes NaeI and NarI.

Authors:  Bram van den Broek; Francesco Vanzi; Davide Normanno; Francesco S Pavone; Gijs J L Wuite
Journal:  Nucleic Acids Res       Date:  2006-01-10       Impact factor: 16.971

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.